Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Oakdell Pharmacy, LLC
WARNING LETTER
•Oakdell Pharmacy, LLC•March 1, 2013

Oakdell Pharmacy, LLC – FDA Warning Letter, Mar 1, 2013

Record Details

The FDA issued a Warning Letter to Oakdell Pharmacy, Inc. following inspections in 2013 and 2014, revealing the firm produced drug products without valid prescriptions for individually-identified patients. This practice means these drugs do not qualify for exemptions under FDCA Section 503A and are misbranded under section 502(f)(1) due to inadequate directions for use. Serious deficiencies in sterile drug product practices were also observed, including insanitary conditions like porous workbenches and poor aseptic technique, causing sterile products to be adulterated under section 501(a)(2)(A).

Additionally, significant Current Good Manufacturing Practice (CGMP) violations (21 CFR Parts 210 and 211) led to adulteration under section 501(a)(2)(B). These included failures in personnel clothing (21 CFR 211.28(a)), equipment maintenance for aseptic conditions (21 CFR 211.42(c)(10)(vi)), environmental monitoring (21 CFR 211.42(c)(10)(iv)), written procedures for preventing microbiological contamination and process validation (21 CFR 211.113(b)), cleaning/disinfecting systems (21 CFR 211.42(c)(10)(v)), and unsupported expiration dates (21 CFR 211.137(a)).

FDA mandates a comprehensive assessment of operations, especially aseptic processing, with a third-party consultant recommended, to implement 21 CFR Part 211 compliant corrections and address misbranding. Failure to correct these violations promptly may result in legal action. A written response detailing corrective actions is required within fifteen working days.

Company
Oakdell Pharmacy, LLC
Inspection date
March 1, 2013
Product type
Drugs
Office
Dallas District Office
Person
  • Reynaldo Rodriguez (District Director)
View Company Profile

ID · dc3cd7c3-b454-430a-b1a9-60e3e21449f3

Violation Codes10
21 U.S.C. 352(f)(1)21 U.S.C. 351(a)(2)(A)21 U.S.C. 331(k)21 CFR 211.28(a)21 CFR 211.42(c)(10)(vi)21 CFR 211.42(c)(10)(iv)21 CFR 211.113(b)21 CFR 211.42(c)(10)(v)21 CFR 211.137(a)21 CFR 210

Full citation text and observation details available on the Dashboard.

Other documents for Oakdell Pharmacy, LLC
  • 483 - 2013-03-01March 1, 2013

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Oakdell Pharmacy, LLC
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.